Two-thirds of Americans approve of editing human DNA to treat disease
By Alessandra Potenza,
The Verge
| 08. 30. 2017
About two-thirds of Americans support the use of gene editing to treat diseases, according to a new survey. But opinions vary a lot based on people’s religious beliefs and how much they know about gene editing in general.
The research, published earlier this month in Science, shows that across the board, people want to be involved in a public discussion about editing the human genome. And that conversation with scientists and public officials needs to happen now, as the technology is still developing, says study co-author Dietram Scheufele, a science communication scholar at the University of Wisconsin-Madison. The results are based on a survey of 1,600 US adults conducted in December 2016 and January 2017.
The goal of the survey was to probe public opinion on a revolutionary piece of technology that’s advancing fast, Scheufele tells The Verge. The advent of powerful gene editing tools like CRISPR is making editing human DNA incredibly easy and precise. The technology holds the potential to rid humanity of diseaseslike sickle cell anemia. Earlier this month, researchers in the US...
Related Articles
By Vuyile Madwantsi, Independent Online | 08.22.2025
Imagine this: a future where parents could choose their baby’s eye colour, height or even intelligence.
Sounds like science fiction, right? But it’s closer than you think.
Let’s start with a simple, human truth: most of us want healthy children...
By Jacob Bogage, The Washington Post | 09.03.2025
The conservative group behind the Project 2025 governing playbook for President Donald Trump’s second term is set to propose sweeping revisions to U.S. economic policy meant to encourage married heterosexual couples to have more children.
The Heritage Foundation, a right-wing...
By Harry Hunter, PET BioNews | 08.11.2025
The Parliamentary Office of Science and Technology has announced plans to publish a POSTnote and called for submissions on surrogacy law in the UK and internationally.
The current UK surrogacy laws, largely based on legislation from the 1980s, have been...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...
